Peer-Reviewed Publications

CPCE investigators are international experts in their clinical effectiveness-related fields, and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here you can access CPCE journal article abstracts by author, title, or year.

Found 165 results
Author Title [ Year(Asc)]
Filters: Author is Aplenc, Richard  [Clear All Filters]
2022
McNerney KO, Oranges K, Seif AE, et al. "Acute Left Ventricular Dysfunction Following Gemtuzumab Ozogamicin in Two Pediatric AML Patients." J Pediatr Hematol Oncol. 2022;44(2):e507-e511.
Andolina JR, Wang Y-C, Ji L, et al. "Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children's Oncology Group experience." Bone Marrow Transplant. 2022.
Pommert L, Cooper TM, Gerbing RB, et al. "Blood Count Recovery Following Induction Therapy for Acute Myeloid Leukemia in Children Does Not Predict Survival." Cancers (Basel). 2022;14(3).
Hoff FW, van Dijk AD, Qiu Y, et al. "Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children's Oncology Group study." Haematologica. 2022.
Ding L, Szymczak JE, Evans E, et al. "Factors that contribute to disparities in time to acute leukemia diagnosis in young people: an in depth qualitative interview study." BMC Cancer. 2022;22(1):531.
Devine KJ, Diorio C, Richman SA, et al. "Guideline for Children With Cancer Receiving General Anesthesia for Procedures and Imaging." J Pediatr Hematol Oncol. 2022.
Stevens AM, Horton TM, Glasser CL, et al. "IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children's oncology group report." Pediatr Hematol Oncol. 2022:1-12.
Elsayed AH, Cao X, Mitra AK, et al. "Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy Augmentation." J Clin Oncol. 2022:JCO2101422.
Miller TP, Getz KD, Li Y, et al. "Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group." Lancet Haematol. 2022.
Yi JS, Chambers TM, Getz KD, et al. "A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment." Haematologica. 2022.
Kotch C, Avery R, Getz KD, et al. "Risk Factors for Treatment Refractory and Relapsed Optic Pathway Glioma in Children with Neurofibromatosis Type 1." Neuro Oncol. 2022.
Elgarten CW, Otto WR, Shenton L, et al. "Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia." Infect Control Hosp Epidemiol. 2022:1-8.
2021
Mangum DSpencer, Meyer JA, Mason CC, et al. "Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia." JAMA Oncol. 2021.
van Dijk AD, Hoff FW, Qiu Y, et al. "Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-κB subunit RelA." Proteomics Clin Appl. 2021:e2100072.
Elgarten CW, Li Y, Getz KD, et al. "Broad spectrum antibiotics and risk of graft-versus-host disease in pediatric patients transplanted for acute leukemia: association of carbapenem use with risk of acute GVHD." Transplant Cell Ther. 2021;27(2):177.e1-177.e8.
Huang BJ, Smith J, Wang J, et al. "CBFB-MYH11 Fusion Transcripts Distinguish Acute Myeloid Leukemias with Distinct Molecular Landscapes and Outcomes." Blood Adv. 2021.
Lamble AJ, Brodersen LEidenschin, Alonzo TA, et al. "CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group." J Clin Oncol. 2021:JCO2101595.
Leahy ABarz, Newman H, Li Y, et al. "CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials." Lancet Haematol. 2021;8(10):e711-e722.
Tarlock K, Lamble A, Wang J, et al. "CEBPA bZip Mutations are Associated with Favorable Prognosis in de novo AML: A Report from the Children's Oncology Group." Blood. 2021.
O'Connor MJ, Zhang X, Griffis H, et al. "Center Variation in Indication and Short-Term Outcomes after Pediatric Heart Transplantation: Analysis of a Merged United Network for Organ Sharing - Pediatric Health Information System Cohort." Pediatr Cardiol. 2021.
Miller TP, Marx MZ, Henchen C, et al. "Challenges and Barriers to Adverse Event Reporting in Clinical Trials: A Children's Oncology Group Report." J Patient Saf. 2021.
Lalonde E, Rentas S, Wertheim G, et al. "Clinical impact of genomic characterization of 15 patients with acute megakaryoblastic leukemia-related malignancies." Cold Spring Harb Mol Case Stud. 2021;7(2).
Getz KD, Alonzo TA, Sung L, et al. "Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group." Pediatr Blood Cancer. 2021:e29313.
Leahy ABarz, Schwartz LA, Li Y, et al. "Electronic symptom monitoring in pediatric patients hospitalized for chemotherapy." Cancer. 2021.
Miller TP, Aplenc R. "Evolution of Hematology Clinical Trial Adverse Event Reporting to Improve Care Delivery." Curr Hematol Malig Rep. 2021.

Pages